Boston, MANCT06891911Now EnrollingIRB Ready

Hypertension Clinical Trial in Boston, MA

Access cutting-edge hypertension treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Beth Israel Deaconess Medical Center

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access hypertension specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hypertension treatment provided free

Apply for This Boston Location

Check if you qualify for this hypertension clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This Hypertension Study in Boston

GoFreshSE is a randomized control trial, testing the effects of a home-delivered, dietitian-assisted, DASH-patterned grocery intervention on blood pressure in adults with high blood pressure in Florida, Georgia, and Tennessee.

Sponsor: Beth Israel Deaconess Medical Center

Who Can Participate

Inclusion Criteria

Resting systolic blood pressure of 120 to \<160 mm Hg and diastolic blood pressure \<110 mm Hg
Resident of Florida, Georgia, and Tennessee
Able to receive home-delivered groceries or pick them up at a convenient location and willing to eat only the groceries provided over a 4-week period
Have access to refrigeration, cooking appliances, and Wi-Fi/cellular service
Have access to mobile device or computer to be able to conduct grocery orders via video conference and send/receive text messages
Willing and able to complete required measurement procedures
Able to provide consent for the study
Has access to a primary care team, urgent care center, or emergency room the study team can refer to for follow up care if warranted during the study

Exclusion Criteria

A. Laboratory Exclusions:
Serum potassium ≥5.0 mmol/L or \<3.5 mmol/L
Estimated glomerular filtration rate (eGFR) \<30 mL/min per 1.73 m\^2 by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation
Hemoglobin A1c ≥6.5% B. Medication Exclusions: Unstable doses (i.e. a change in the 6 months prior to screening or randomization or planning to start within study period) of the following:
GLP-1 and dual GLP-1/GIP receptor agonists
Anti-hypertension medications
Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Glucose lowering medications Use of any of the following medications:
Potassium supplement, except if part of a multivitamin
Warfarin (Coumadin)
Chronic oral corticosteroid (intermittent use is okay)
Weight loss medications (non-GLP-1 receptor agonists)
Sulfonylurea or any insulin use Any medication not compatible with participation as determined by the investigators C. Physical Exclusions:
Systolic blood pressure: \<120 or ≥160 mm Hg or diastolic blood pressure ≥110 mm Hg
Arm circumference \>52 cm (or the upper limit of the validated BP device) D. Medical History Exclusions:
Self-reported weight loss or gain of 15 pounds during prior 2 months
Active cardiovascular disease or any event in the prior 6 months, including coronary artery bypass grafting (CABG), percutaneous transluminal coronary angioplasty (PTCA), myocardial infarction (MI), cerebrovascular accident (CVA), or congestive heart failure (CHF) exacerbation requiring hospital admission
Cancer diagnosis or treatment in the last 2 years (non-melanoma skin cancer or localized breast or prostate or bladder cancer not requiring systemic therapy is acceptable)
Gastrointestinal surgery or history that affects nutrition absorption or requires a specific diet that will deter DASH diet adherence
Pregnancy or lactation or planned pregnancy during the study period
Any emergency department (ED) visit for asthma or chronic obstructive pulmonary disease (COPD) in the last 6 months
Hypoglycemia hospitalization in the last 12 months
Any other serious illness or condition not compatible with participation as determined by the investigators E. Lifestyle and Other Exclusions:
Significant food allergies, preferences, intolerances, or dietary requirements that would interfere with diet adherence
Consumption of more than 14 alcoholic drinks per week or consumption of more than 6 drinks on one or more occasion per week
Active substance use disorder that would interfere with participation
Extreme food insecurity
Participation in or planning to start weight loss program
Current participation in another clinical trial that could interfere with the study protocol
Anticipated change in residence outside of eligible states prior to the end of the study
Families with more than 6 adults at dinner time (children count as half an adult) F. Investigator discretion

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT06891911) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hypertension Treatment Options in Boston, MA

If you're searching for hypertension treatment options in Boston, MA, this clinical trial (NCT06891911) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hypertension specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hypertension clinical trials near you to find additional studies recruiting in your area.

More Hypertension Trials in Boston, MA

See all hypertension clinical trials recruiting in Boston — not just this study.

Browse Hypertension Trials in Boston →

Browse More Trials by Condition

Hypertension TrialsPulmonary Embolism TrialsPulmonary Hypertension TrialsGlaucoma TrialsPreeclampsia TrialsAll Conditions →

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA